SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-011997
Filing Date
2022-03-28
Accepted
2022-03-28 16:50:21
Documents
5
Effectiveness Date
2022-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 dice-s8.htm S-8 155399
2 EX-5.1 dice-ex51_51.htm EX-5.1 13193
3 EX-23.1 dice-ex231_53.htm EX-23.1 2373
4 EX-FILING FEES dice-exfilingfees_52.htm EX-FILING FEES 27239
5 GRAPHIC g2xoalk2lixs000001.jpg GRAPHIC 58506
  Complete submission text file 0001564590-22-011997.txt   280156
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263901 | Film No.: 22776096
SIC: 2834 Pharmaceutical Preparations